Pharma Two B Ltd.   Report issue

For profit Phase 3
Founded: Rehovot Israel (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2013
NCT01968460
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Pharma2b LTD | Pharma Two B Ltd.

Active Ingredients

Drugs in Phase 3 Trials (2)

pramipexole (mirapex) (2 trials)

rasagiline (azilect) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Parkinson Disease (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2